Invited Seminars and Lectures, Presentations at Scientific Meetings (1990 - 1999)
  1. Bronchoalveolar Lavage: Diagnosis of Lung Rejection - Lung Tranpslantation Course, New Orleans, LA, February, 1990.
  2. Cyclosporine/FK506 - Immunology and the Liver AAASLD Single Topic Conference, Washington, DC, April, 1990.
  3. Comparison Between Alloreactivity of Lung Biopsy Derived Lymphocytes and BAL Cells - ISHI, Fort Lauderdale, FL, April, 1990.
  4. Pathogenesis of Bronchiolitis Obliterans - IV Toronto Lung Transplantation Seminar, Toronto, Canada, May, 1990.
  5. Alloreactivity of Lung Biopsy Lymphocytes: Correlation with Acute Rejection and Bronchiolitis Obliterans - ASTP, Chicago, IL, May, 1990.
  6. Bronchoalveolar Lavage and Primed Lymphocyte Testing in Lung Allograft - Surgical Grand Rounds, Montreal General Hospital, Division of Cardiovascular and Thoracic Surgery, Toronto, Canada, June, 1990.
  7. Immunological Monitoring of Heart and Lung Transplant Recipients - Seminar, Division of Transplantation Immunology, Chaim Sheba Medical Center, Tel-Aviv, Israel, July, 1990.
  8. FK506: Mechanism of Action - Seminar, Beilinson Hospital, Petah-Tickva, Israel, July, 1990.
  9. Propagation of Lymphocytes from Transplant Biopsies: Clinical Relevance - Hadassah Medical Center, Jerusalem, Israel, July, 1990.
  10. In Vitro Effects of Immunosuppressive Drugs - Seminar, Bar-Ilan University, Ramat-Gan, Israel, July, 1990.
  11. Presence of Donor-Specific Alloreactivity in Histological Normal Lung Allografts is Predictive of Subsequent Bronchiolitis Obliterans - XIII International Congress of the Transplant Society, San Francisco, CA, August, 1990.
  12. Correlation Between Plasma Levels of FK506 and Acute Cellular Rejection of Human Liver Transplants - XIII International Congress of the Transplantation Society, San Francisco, CA, August, 1990.
  13. Immunologic Studies Following Lung and Heart/Lung Transplantation - The 4th Grover Conference on Clinical Pulmonary Hypertension: Diagnosis and Treatment, Lost Valley Ranch, CO, September, 1990.
  14. Immunosuppressive Drugs: Mechanisms of Action - Cedar-Sinai Medical Center, Los Angeles, CA, November, 1990.
  15. Cyclosporine and FK506: Mechanism of Action and Monitoring. Relation of Drug Levels to In Vitro Suppression of Immune Response - Current Trends in Immunosuppression of Renal Disease and Kidney Transplantation, Skovde, Sweden, November, 1990.
  16. Immunosuppressive Effects of Rapamycin and FK506 on Human T Cells - International Society for Heart Transplantation, 11th Annual Meeting, Paris, France, April, 1991.
  17. Immunological Monitoring of Lung Transplant Recipients - Universita di Roma (Renna Molajoni), Rome, Italy, April, 1991.
  18. Mechanisms of Action of Immunosuppressive Drugs - University di Roma (Professor Cortesini), Rome, Italy, April, 1991.
  19. Analysis of Lymphocytes Directly Recovered from the Allograft - International Symposium on Transplant Monitoring, Jerusalem, Israel, June, 1991.
  20. In Vitro Assessment of FK506 Immunosuppressive Activity in Transplant Patients - FK506 First International Congress, Pittsburgh, PA, August, 1991.
  21. Comparative In Vitro Studies on the Immunosuppressive Activities of Mycophenolic Acid, Bredinin, FK506, Cyclosporine and Rapamycin - FK506 First International Congress, Pittsburgh, PA, August, 1991.
  22. CMV-Specific Responses in BAL Cells - Second Basic Sciences Symposium, The Transplantation Society, Oxford, England, September, 1991.
  23. Lymphocyte Abnormalities in Heart/Lung Transplantation - NHLBI Workshop on Interstitial Pneumonia after Bone Marrow Transplants, Washington, DC, September, 1991.
  24. Short-Term Outcome: Role of Bronchoalveolar Lavage in Diagnosis of Lung Rejection - ATS/NHLBI Workshop on Lung Transplantation, Dallas, TX, October, 1991.
  25. Effects of Immunosuppressive Macrolides and Nucleotide Synthetase Inhibitors on Proliferation of Lymphoid Cells Induced via Distinct Signal Transduction Pathways - 17th Annual Meeting of ASHI, Washington, DC, October, 1991.
  26. Transplant Monitoring Workshop - 17th Annual Meeting of ASHI, Washington, DC, October, 1991.
  27. New Advances with Immunosuppressive Drugs - Society for Biological Therapy, Pittsburgh, PA, November, 1991.
  28. Lymphocyte Propagation from Cardiac and Pulmonary Allografts in Acute and Chronic Rejection - Tranpslantation 1992, L'Aquila, Italy, February, 1992.
  29. New Strategies for Immunosuppression 0 Invited by Dr. Francavilla, Bari, Italy, February, 1992.
  30. In Vitro Immunosuppressive Properties of Brequinar - FDA Workshop, Washington, DC, February, 1992.
  31. In Vitro Immunosuppressive Effects of Brequinar - Dupont Pharmaceuticals, Delaware, March, 1992.
  32. Immunosuppressive Effects of Purine and Pyridine Inhibitors - Cell Transplant Society, Pittsburgh, PA, June, 1992.
  33. Immunologic Correlates of Late Lung Rejection and Bronchiolitis Obliterans - NHLBI Workshop on Immunological Aspects of Lung Transplantation, Bethesda, MD, June, 1992.
  34. Comparative In Vitro Studies on the Immunosuppressive Effects of Purine and Pyrimidine Synthesis Inhibitors - XIV International Congress of the Transplantation Society, Paris, France, August, 1992.
  35. Mechanisms of Actin and Purine and Pyrimidine Inhibitors - 8th International Congress of Immunology, Budapest, Hungary, August, 1992.
  36. Clinical Xenotransplantation: Recent Experience with Baboon Liver Transplant Recipients - Xenotransplantation Workshop, New York, September, 1992.
  37. Intragraft Cytokine Profile During Human Lung Allograft Rejection - 18th Annual Meeting, ASHI, Kansas City, MO, October, 1992.
  38. Immunological Monitoring of Solid Organ Transplant Recipients - Workshop at the 18th Annual Meeting of ASHI, Kansas City, MO, October, 1992.
  39. Status of Ex-Vivo Lymphocyte Tests - FDA, Rockville, MD, October, 1992.
  40. Autologous Bone Marrow Transplant for Treatment of Graft-versus-Host Disease in a Combined Bone Marrow Transplant Recipient - Symposium on Tolerance Induction, Breckenridge, CO, January, 1993.
  41. Clinical Relevance of Lymphocyte Analysis in Cardiac and Pulmonary Transplantation - Invited Lecture in course sponsored by CDER Staff College in the Immunosuppressive Drug Development and Transplantation Science, FDA, Rockville, MD, March, 1993.
  42. Current Strategies of Immunosuppression - Midwest ASHI Regional Meeting, Columbus, OH, May, 1993.
  43. cytokine Profile During Lung Allograft Rejection - The American Association of Immunologists, Denver, CO, May, 1993.
  44. Microchimerism in Long-Term Solid Organ Transplant Recipients Detection and Immunologic Monitoring - Columbia University, New York, NY, May, 1993.
  45. Transplantation Immunology: Basic Understanding and New Concepts - American College of Clinical Pharmacy Annual Meeting, Reno, NV, August, 1993.
  46. Current Approaches for Immunological Monitoring of Solid Organ Transplant Recipients: - Why, When, and How - (Workshop), 19th Annual Meeting of ASHI, Phoenix, AZ, October, 1993.
  47. Specificity and Functions of Graft Infiltrating Cells - 7h International Workshop of Cytology and Histology of Transplantation, Buenos Aires, Argentina, November , 1993.
  48. Importance of BAL vs. Biopsy for the Diagnosis of Lung Rejection and Infection - 7th International Workshop of Cytology and Histology of Transplantation, Buenos Aires, Argentina, November, 1993.
  49. Cellular Immune Reactivity Following Baboon to Human Liver Xenotransplantation - Second International Congress on Xenotransplantation, Cambridge, England, September, 1993.
  50. Baboon to Human Liver Xenotransplantation: Monitoring of Donor-Specific Humoral Response - Second International Congress on Xenotransplantation, Cambridge, England, September 1, 993.
  51. Cytokine Profiles in Cytomegalovirus (CMV) and Epstein Barr Virus (EBV) Infections and the Effect on Allograft Outcome - Third Basic Sciences Symposium, Big Sky, Montana, September, 1993.
  52. Different T Helper Subset Activation During Cytomegalovirus (CMV) and Epstein Barr Virus (EBV) Infection in Solid Organ Transplantation - (Best Abstract) - 19th Annual Meeting of ASHI, Phoenix, AZ, October, 1993.
  53. Immune Status of Recipients Following Bone Marrow Augmented Solid Organ Transplantation - ASTP Meeting, Chicago, IL, May, 1994.
  54. Functional Aspects of Host: Epstein Barr Virus Interactions. Studies in Normal Seropositive Individuals and in Transplant Patients with Lymphoproliferative Disorders - ASTP Meeting, Chicago, IL, May, 1994.
  55. Immune Status of Recipients Following Bone Marrow Augmented Solid Organ Transplantation - Invited Speaker by Dr. Sutherland, Transplant Research Conference, Minneapolis, MN, August, 1994.
  56. Serial Evaluation of Immune Profile Bone Marrow and Whole Organ Transplant Recipients - XVth World Congress of the Transplantation Society, Kyoto, Japan, August/September, 1994.
  57. Clinical Studies of Intragraft Cytokine Expression in Solid Organ Transplantation - Conference on Nucleic Acid, San Diego, CA, November, 1994.
  58. Cytokine Measurements for Predicting Organ Transplant Rejection. Beaumont Hospital's 4th Annual Seminar on "DNA Technology in the Clinical Laboratory", Detroit, MI, March 10, 1995.
  59. CMV Pathogenesis in Lung Transplantation - Pulmonary Grand Rounds, University of Pittsburgh, March 31, 1995.
  60. Sequential Immune Studies in Bone Marrow Augmented Solid Organ Transplant Recipients: Heart and Lung and Other Solid Organ Transplants - 15th Annual Meeting of International Society for Heart and Lung Transplantation, San Francisco, CA, April 5-7, 1995.
  61. CMV Memory Response in Lung Transplant Recipients - Research conference, Thoracic Surgery, University of Pittsburgh, April 11, 995.
  62. BM Augmented Liver Transplantation: An update, VA Hospital, Pittsburgh, PA, April 21, 1995.
  63. Host Immune Response to CMV in Lung Transplantation - Pathology Department, Ohio State University Medical School, Columbus, OH, April 24, 1995.
  64. Role of Lymphocytes in the Lung - Biology of Lung Transplant Symposia, The American Pediatric Society and The Society for Pediatric Research, San Diego, CA, May 8, 1995.
  65. An Update on Immunological Monitoring of Bone Marrow Augmented Organ Transplant Recipients - 14th Annual Meeting of American Society of Transplant Physicians, Chicago, IL, May 16, 1995.
  66. Early Inflammatory Events in a Rat Infectious Model of Otitis Media - Recent Advances in Otitis Media, Ft. Lauderdale, FL, June 3-8, 1995.
  67. Acute Cellular Rejection in Organ Transplantation- Transplant Pathology, University of Pittsburgh, August 28, 1995.
  68. CMV Pathogenesis in Lung Transplantation - 4th Basis Science Symposia of the Transplantation Society, Noordwijkerhout, The Netherlands, September 17-20, 1995.
  69. CMV Pathogenesis in Lung Transplantation - American Society for Histocompatibility and Immunogenetics Annual Meeting, Dallas, TX, October 6-11, 1995.
  70. Donor-Specific Hyporeactivity in Bone Marrow Augmented Solid Organ Transplant Recipients - American Society for Histocompatibility and Immunogenetics Annual Meeting, Dallas, TX, October 6-11, 1995.
  71. Presentation of Donor Antigens by Lung Allograft Fibroblasts is Resistant to Inhibition by Cyclosporine and Tacrolimus - American Society for Histocompatibility and Immunogenetics Annual Meeting, Dallas, TX, October 6-11, 1995.
  72. Lack of CMV-Specific Memory Response is Associated with Recurrent CMV Disease in Lung - American Society for Histocompatibility and Immunogenetics Annual Meeting, Dallas, TX, October 6-11, 1995.
  73. Host Immune Response to CMV in Lung Transplant Recipients: Facts and Fiction - Immunology Conference, University of Pittsburgh Cancer Institute, November 9, 1995.
  74. Immunological Monitoring of Transplant Recipients- Transplant Pathology Division, University of Pittsburgh, November 9, 1995.
  75. The Immunopathology of Lung Rejection - Lung Pathology Course, Pittsburgh, PA, November 11, 1995.
  76. Mechanisms of CMV-Induced Pathogenesis Following Lung Transplantation - Belinson Medical Center, Petah-Tickva, Israel, January 24, 1996.
  77. Bone Marrow Augmentation in Organ Transplantation - Israel Transplantation Society, Dead Sea, Israel, January 26, 1996.
  78. Lack of T Cell Memory is Associated with Recurrent CMV Infection in Lung Transplant - 16th International Society of Heart and Lung Transplantation, New York, NY, March 16, 1996.
  79. Host Immune Response to CMV Infection in Lung Transplant Recipients - 16th International Society of Heart and Lung Transplantation, New York, NY, March 16, 1996.
  80. CMV Pathogenesis in Lung Transplantation - CT Surgery Presentation, University of Pittsburgh Medical Center, March 27, 1996.
  81. Three Years of Follow-Up of Bone Marrow Augmented Organ Transplant Recipients: The Impact on Donor-Specific Immune Modulation - 15th Annual Meeting of American Society of Transplant Physicians, Dallas, TX, May 26-29, 1996.
  82. Clinical Significance of CMV-Specific Memory T Helper Responses in Lung Transplant Recipients - 15th Annual Meeting of American Society of Transplant Physicians, Dallas, TX, May 26-29, 1996.
  83. Two Types of CMV-Specific Memory Responses - University of Pittsburgh Cancer Institute Retreat, Johnstown, PA, June 23, 1996.
  84. Three Years of Follow-up of Bone Marrow Augmented Organ Transplant Recipients: The Impact on Donor-Specific Immune Modulation - XVI World Congress of the Transplantation Society, Barcelona, Spain, August 25, 1996.
  85. Clinical Significance of CMV-Specific Memory T Helper Responses in Lung Transplant Recipients - XVI World Congress of the Transplantation Society, Barcelona, Spain, August 27, 1996.
  86. Donor-Specific Bone Marrow Infusion in Lung Transplant Recipients: Rationale and Clinical Results - 2nd International Congress on Lung Transplantation, Paris, France, September 19-20, 1996. Invited speaker.
  87. Augmented Donor-Specific Chimerism and Immune Modulation in Solid Organ Transplant Recipients Following Infusion of Unmodified Donor Bone Marrow - American Society For Histocompatibility and Immunogenetics, San Diego, CA, October 13, 1996.
  88. CMV-Specific T Cell Memory Elicited by CMV-Infected A549 Alveolar Epithelial Cell Line: Potential Role of Donor CMV-infected Cells Promoting Chronic Inflammation in Lung Transplant Recipients - American Society for Histocompatibilty and Immunogenetics, San Diego, CA, October 12, 1996.
  89. Host Immune Response to CMV: Facts and Fiction - Immunology Session, University of Pittsburgh Medical Center, October 24, 1996.
  90. CMV Immunopathology of Human Lung Transplantation (Invited speaker) - Saint Louis Bilateral Workshop, USA-Italy on Lung Transplantation, November 1, 1996.
  91. Upregulation of Proinflammatory Cytokines in a Rat Model of Otitis Media- Program Project Research Retreat, University of Pittsburgh, November 8, 1996.
  92. CMV-specific Immune Responses - Research presentation for Pulmonary Division Conference, University of Pittsburgh, November 7, 1996.
  93. Molecular Basis for Solid Organ Acceptance (Invited speaker) - Molecular Pathology of Human Disease, San Diego, CA, November 22, 1996.
  94. HLA and Cell-Medicated Responses - Presentation for Pathology Residents, University of Pittsburgh, December 11, 1996.
  95. Cytokine and Cellular Immunity in CMV-Infection in Lung Transplant Recipients - Allergy/Immunology Group, University of Pittsburgh, December 17, 1996.
  96. Two Types of CMV-Specific Memory Responses: Potential Role of Donor Infected Target Cells in Recruitmentof Activated T Cells to the Graft - CMV Workshop, Orange Beach, AL, March 5-9, 1997.
  97. Donor-Specific Bone Marrow Infusion in Lung Transplant Recipients: The Impact on Immune Modulation and Delayed Graft Rejection, International Heart & Lung Meeting, London, April 3, 1997.
  98. Two Types of CMV-Specific Memory Responses: Potential Role of Donor Infected Target Cells in Recruitment of Activated T Cells to the Graft, International Heart & Lung Meeting, London, April 4, 1997.
  99. New Strategies for the Prevention of CMV-Induced Artherosclerosis and Obliterative Bronchiolitis. Breakfast Symposia, International Heart & Lung Meeting, London, April 5, 1997.
  100. Post Transplant Immune Monitoring Workshop - Annual ASTP Meeting, Chicago, IL, May 10-14, 1997.
  101. Immune Monitoring/Infiltrating Cells - ASHI Educational Workshop, Niagara-on-the-Lake, Ontario, Canada, May 15-16, 1997.
  102. Two Types of CMV-Specific Memory Responses: Potential Role of Donor Infected Target Cells in Recruitment of Activated T Cells to the Graft - CMV Related Pathology Workshop, Frankfort, Germany, August 27-31, 1997.
  103. Present Status of Transplant Immunology - 7th World congress Cardio-Thoracic Surgeons, Dusseldorf, Germany, September 2-5, 1997.
  104. Phenotypic and Functional Characterization of Two Types of CMV-Specific T Helper memory Responses in Seropositive Normal Individuals - Basic Science Meeting, Chataqua, NY, September 6-11, 1997.
  105. Clinical Significance of CMV-Specific Memory T Helper Responses in Lung Transplant Recipients: Lower Risk for Recurrent CMV Disease and Recruitment of Inflammatory Cells by Infected Donor Parenchyma Cells - Basic Science Meeting, Chataqua, NY, September 6-11, 1997.
  106. Combined Donor Bone Marrow Infusion and Solid Organ Transplantation: The Impact on Immune Modulation and Delayed Graft Rejection - Annual ASHI Meeting, Atlanta, GA, October 14-19, 1997.
  107. Immunomonitoring After Human-Limb Allotransplantation - Clinical Composite Tissue Allotransplantation, Louisville, KY, November 19-20, 1997.
  108. Role of Experimental Models for Heart and Lung Transplant Chronic Rejection - ISHLT Annual Meeting (Chair and Summarize), Chicago, IL, April 15, 1998.
  109. Functional and Phenotypical Analysis of Two Distinct CMV-Specific T Helper Memory Cells - Blood Research Institute, Milwaukee, WI, May 8, 1998.
  110. Immune Monitoring: P Values and Guidance for the Clinician Workshop - 17th Annual Meeting of the American Society of Transplant Physicians, Chicago, IL, May 10, 1998.
  111. Bone Marrow Augmented Organ Transplant Recipients: The Impact of Donor Specific Immune Modulation - SEOPF Scientific Session, Baltimore, MD, May 28, 1998.
  112. Post-Transplant Monitoring After Solid Organ Transplantation - ASHI's Southeast Regional Education Workshop, Richmond, VA, June 4, 1998.
  113. Two Types of CMV-Specific Memory Responses in Lung Transplant Recipients - Transplantation Society Meeting, Montreal, Canada, July 14, 1998.
  114. Chair Abstract Session on Lung Transplantation - Transplantation Society Meeting, Montreal, Canada, July 14, 1998.
  115. Bone Marrow Augmentation for Solid Organ Transplantation: Impact on Donor-Specific Hyporesponsiveness -Dendritic Cell and Chimerism Meeting, Pittsburgh, PA, September 28, 1998.
  116. Organize and Co-Chair Scientific Program for 24th Annual ASHI Meeting - Vancouver, Canada, October 11-15, 1998.
  117. Intracellular Cytokine Production in Lung Transplant Recipients - Poster presentation, 24th Annual ASHI Meeting, Vancouver, Canada, October 11.-15, 1998.
  118. CMV-Specific T Helper Memory Responses in Lung Transplant Recipients: Characterization and Clinical Significance - Poster presentation, 24th Annual ASHI Meeting, Vancouver, Canada, October 11-15, 1998.
  119. Organize along with Angus Thomson and John Fung - Inaugural Thomas E. Starzl Transplantation Institute Retreat, Pittsburgh, PA, December 8-9, 1998.
  120. Co-Chair Cardiothoracic Section (with Ken McCurry) - Inaugural Thomas E. Starzl Transplantation Institute Retreat, Pittsburgh, PA, December 8-9, 1998.
  121. Two Types of CMV-Specific T Helper Memory Responses - Inaugural Thomas E. Starzl Transplantation Institute Retreat, Pittsburgh, PA, December 9, 1998.
  122. GB and IL-15 in RNA in Rejection and Quiescence in Lung Transplant Recipients - Clinical Histocompatibility Workshop, Palm Springs, CA, March 3-7, 1999.
  123. Cytokine Genotyping in Heart and Lung Transplant Recipients - Clinical Histocompatibility Workshop, Palm Springs, CA, March 3-7, 1999.
  124. The Impact of Aerosolized Cyclosporine on Lung Transplantation - UPMCI Immunology Program, Pittsburgh, PA, March 11, 1999.
  125. Detection of Donor Chimerism and T cell Activation Markers in Solid Organ Transplantation - DNA Technology in Clinical Laboratory - Invited Symposium Speaker, Beaumont Hospital, Detroit MI, March 25-26, 1999.
  126. Post-transplant Immunological Monitoring - Laboratory Medicine Meeting, Miami, FL, April 9-10, 1999.
  127. Competitive RT-PCR for granzyme-B, IL-15 and Routes for Molecular Diagnosis of Lung Allograft Rejection, ISHLT, San Francisco, CA, April 21-26, 1999.
  128. High Frequency of Intragraft IFN-8 Producing CD8+ T Cells is Predictive of Lung Allograft Rejection, ISHLT, San Francisco, CA, April 21-26, 1999.
  129. Indirect Allorecognition and Clinical Significance, Chair and Organize Luncheon Symposium, ASTP, Chicago, IL, May 15-18, 1999.
  130. CMV Pathogenesis in Lung Transplantation - Inivited Speaker, Pathology Department, Madison, WI, May 19, 1999.
  131. Cytokine Gene Polymorphism - Seminar, Allergy and Immunology, Children's Hospital of Pittsburgh, Pittsburgh, PA, June 15, 1999.
  132. Whole Blood Assay for Intracellular Cytokine - Transplant Institute, Pittsburgh, PA, June 21, 1999.
  133. The Impact of Cytokine Gene Polymorphism in Pediatric Heart and Lung Transplantation - Pathology Staff, Research Presentation, Pittsburgh, PA, August 18, 1999.
  134. CMV Round Table Workshop. Invited speaker, Belgium, September 19, 1999.
  135. Viruses in Organ Transplantation: What can we learn from them? Invited Plenary speaker, ASHI, New Orleans, LA, October 20-24, 1999.
  136. CMV and Chronic Rejection in Lung Transplantation, Invited Plenary, ASHI, New Orleans, LA, October 20-24, 1999.
  137. Intrathymic Inoculation of Donor Bone Marrow Cells with Concomitant Pediatric Heart Transplantation: The Impact on Donor-Specific Responses, ASHI, New Orleans, LA, October 20-24, 1999.
  138. The Effect of Cytokine Gene Polymorphisms on Graft Outcome in Pediatric Heart Transplant Recipients, ASHI, October 20-24, 1999.
  139. Various Issues in Chronic Rejection in Lung Transplantation, Baltimore, MD, December 6-7, 1999.